iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

NCT04624685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 475

Last updated 2021-10-20

No results posted yet for this study

Summary

Long term follow up of subjects in the IDE study for iStent Inject to monitor safety

Conditions

  • Glaucoma, Open-Angle

Sponsors & Collaborators

  • Glaukos Corporation

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2021-01-20
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624685 on ClinicalTrials.gov